Gwak et al. identified three cases of EGFR del19 (two K745-E749 deletions and one E746-A750 deletion) among 22 cholangiocarcinoma specimens, which were associated with poor prognosis [51]. This evidence concerns the gene EGFR and cholangiocarcinoma.